ZA922309B - Peptides and mixtures thereof for detecting antibodies to hepatitis c virus(hcv) - Google Patents

Peptides and mixtures thereof for detecting antibodies to hepatitis c virus(hcv)

Info

Publication number
ZA922309B
ZA922309B ZA922309A ZA922309A ZA922309B ZA 922309 B ZA922309 B ZA 922309B ZA 922309 A ZA922309 A ZA 922309A ZA 922309 A ZA922309 A ZA 922309A ZA 922309 B ZA922309 B ZA 922309B
Authority
ZA
South Africa
Prior art keywords
hcv
hepatitis
peptides
virus
mixtures
Prior art date
Application number
ZA922309A
Other languages
English (en)
Inventor
Martial Lacroix
Lacroix Martial
Original Assignee
Iaf Biochem Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iaf Biochem Int filed Critical Iaf Biochem Int
Publication of ZA922309B publication Critical patent/ZA922309B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA922309A 1991-04-05 1992-03-30 Peptides and mixtures thereof for detecting antibodies to hepatitis c virus(hcv) ZA922309B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/681,701 US5574132A (en) 1991-04-05 1991-04-05 Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)

Publications (1)

Publication Number Publication Date
ZA922309B true ZA922309B (en) 1992-12-30

Family

ID=24736406

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA922309A ZA922309B (en) 1991-04-05 1992-03-30 Peptides and mixtures thereof for detecting antibodies to hepatitis c virus(hcv)

Country Status (12)

Country Link
US (1) US5574132A (xx)
EP (1) EP0507615A1 (xx)
JP (2) JP3477198B2 (xx)
CN (1) CN1051091C (xx)
AU (1) AU1447492A (xx)
CA (1) CA2107672C (xx)
EG (1) EG20096A (xx)
IE (1) IE921070A1 (xx)
IL (1) IL101425A0 (xx)
NZ (1) NZ242183A (xx)
WO (1) WO1992017493A2 (xx)
ZA (1) ZA922309B (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US6312889B1 (en) 1990-04-04 2001-11-06 Chiron Corporation Combinations of hepatitis c virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
DK0556320T3 (da) * 1990-11-07 1999-10-18 Abbott Lab Monoklonale antistoffer mod Hepatitis C-virus og fremgangsmåde til anvendelse heraf
GB9105871D0 (en) * 1991-03-20 1991-05-08 Inst Cientifico Tecnol Navarra Synthetic peptides
RO117329B1 (ro) * 1991-06-24 2002-01-30 Chiron Corp Emeryville Polipeptide care contin o secventa a virusului hepatitei c
DE4209215A1 (de) 1991-07-04 1993-01-07 Boehringer Mannheim Gmbh Hcv peptidantigene und verfahren zur bestimmung von hcv
WO1993011158A2 (en) * 1991-12-06 1993-06-10 Akzo Nobel N.V. Non-a, non-b peptides
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
AU671623B2 (en) * 1992-03-06 1996-09-05 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and biotinylated peptides used therein
DE4240980A1 (de) * 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh HCV Peptidantigene und Verfahren zur Bestimmung von HCV
KR100312535B1 (ko) * 1993-04-30 2002-06-20 성재갑 혼합항원을이용한씨(c)형간염바이러스의항체진단방법
CA2162557C (en) * 1993-05-12 2004-09-28 Amy J. Weiner Conserved motif of hepatitis c virus e2/ns1 region
JPH07135981A (ja) * 1993-05-28 1995-05-30 Eisai Co Ltd 非ａ非ｂ型肝炎ウイルス遺伝子に由来するｄｎａ及び構成ポリペプチド
US5514539A (en) * 1993-06-29 1996-05-07 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
EP0729973A4 (en) * 1993-10-29 1998-12-30 Srl Inc AN ANTIQUE PEPTIDE COMPOUND AND IMMUNOASSAY PROCEDURE
SE503627C2 (sv) * 1993-12-27 1996-07-22 Euro Diagnostica Ab Peptid, diagnostiskt antigen och förfarande för hepatit C diagnos
CA2172305A1 (en) * 1995-03-30 1996-10-01 Muneo Aoyama Multiple antigenic peptide comprising at least two hepatitis c virus-associated peptides
US5849800A (en) * 1997-03-28 1998-12-15 The Penn State Research Foundation Use of amantadine for treatment of Hepatitis C
US5977299A (en) * 1997-04-07 1999-11-02 Dade Behring Marburg Gmbh Activated peptides and conjugates
US6030771A (en) * 1997-08-25 2000-02-29 Centers For Disease Control And Prevention Mosaic protein and restriction endonuclease assisted ligation method for making the same
JP3514729B2 (ja) * 1998-07-30 2004-03-31 株式会社先端生命科学研究所 Ｃ型肝炎ウイルスの測定方法
US7091324B2 (en) 1998-11-05 2006-08-15 Board Of Trustees Of Leland Stanford Junior University Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes
US6210908B1 (en) 1998-11-11 2001-04-03 Dade Behring Marburg Gmbh Activated peptides and conjugates
AT408721B (de) * 1999-10-01 2002-02-25 Cistem Biotechnologies Gmbh Pharmazeutische zusammensetzung enthaltend ein antigen
AU2001232267A1 (en) * 2000-02-14 2001-08-20 Japan As Represented By Director General Of Agency Of National Institute Of Infectious Deseases Remedies for hepatitis c
AU2001272257A1 (en) * 2000-07-07 2002-01-21 Medmira Inc. Hcv mosaic antigen composition
US7326536B2 (en) * 2001-05-03 2008-02-05 Eli Lilly And Company Agents for treatment of HCV and methods of use
NZ546347A (en) * 2003-10-14 2009-11-27 Intermune Inc Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication
CN103159853A (zh) * 2013-02-23 2013-06-19 浙江家和制药有限公司 全人源抗丙型肝炎病毒核心抗原的基因工程Fab抗体及其制备方法和应用
US9891225B2 (en) * 2013-05-10 2018-02-13 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compositions and methods for simultaneous detection of HCV antigen/antibody

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464474A (en) * 1980-07-09 1984-08-07 Connaught Laboratories Limited Non-A, non-B hepatitis assay and vaccine
US5032511A (en) * 1987-03-31 1991-07-16 Mitsubishi Kasei Corporation DNA fragments coding for antigens specific to non-A non-B hepatitis, expression vectors containing said DNA fragments, transformants and process for producing said antigens
JPS6490197A (en) * 1987-09-30 1989-04-06 Mitsubishi Chem Ind Peptide
HU216017B (hu) * 1987-11-18 1999-04-28 Chiron Corp. Eljárás HCV-1 polipeptidek, HCV-1 polinukleotidok, rekombináns vektorok és gazdasejtek, valamint immunesszé kit, hepatitis C vírusfertőzés elleni vakcinák, a fertőzés kimutatására szolgáló diagnosztikumok előállítására, és immunvizsgálati és vírustenyészt
GB2212511B (en) * 1987-11-18 1992-01-22 Chiron Corp Hepatitis c virus
US5191064A (en) * 1988-09-30 1993-03-02 The Research Foundation For Microbial Diseases (Osaka University) Non-a, non-b hepatitis virus antigen peptide
JPH02167081A (ja) * 1988-12-21 1990-06-27 Tetsuo Nakamura 非Ａ非Ｂ型肝炎ウイルスゲノムＲＮＡ、ｃＤＮＡおよびウイルス抗原蛋白質
HU225068B1 (en) * 1989-03-17 2006-05-29 Chiron Corp Process for producing diagnostics and vaccine of nanbh
RO113059B1 (ro) * 1989-05-18 1998-03-30 Chiron Corp Polinucleotida capabila de hibridizare pe o secventa hcv, metoda pentru detectarea unei secvente hcv si procedeu de eliminare a hcv din sange
EP0416725A3 (en) * 1989-07-14 1991-03-20 Chugai Seiyaku Kabushiki Kaisha Blood-borne non-a, non-b hepatitis specific protein, dna encoding it, and process for its production
DK0414475T3 (da) * 1989-08-25 1998-02-09 Chiron Corp Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier
CA2065287C (en) * 1989-09-15 1999-12-21 Tatsuo Miyamura New hcv isolates
AU638304B2 (en) * 1989-12-22 1993-06-24 Abbott Laboratories Hepatitis c assay
EP0435229A1 (en) * 1989-12-27 1991-07-03 Sanwa Kagaku Kenkyusho Co., Ltd. DNA of non-A, non-B hepatitis virus gene, its clone and use thereof
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
KR940000755B1 (ko) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
EP0445801A3 (en) * 1990-03-08 1992-07-01 Kuraray Co., Ltd. Peptide and its use
HU217025B (hu) * 1990-04-04 1999-11-29 Chiron Corp. Hepatitis C vírus-(HCV) antigénkészítmények az anti-HCV-antitestek kimutatására immunoassay-kben
DK0527815T3 (da) * 1990-04-06 2000-11-06 Genelabs Tech Inc Hepatitis C-virus-epitop
CA2047792C (en) * 1990-07-26 2002-07-02 Chang Y. Wang Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
JP3114731B2 (ja) * 1990-08-14 2000-12-04 国立感染症研究所長 Ｃ型肝炎ウイルス抗体検出用ペプチド抗原及びその使用方法
DK0770679T4 (da) * 1990-11-03 2010-05-10 Siemens Healthcare Diagnostics HCV-specifikke peptider, sammensætninger dertil og anvendelse deraf

Also Published As

Publication number Publication date
CA2107672A1 (en) 1992-10-06
AU1447492A (en) 1992-11-02
WO1992017493A2 (en) 1992-10-15
EG20096A (en) 1997-07-31
WO1992017493A3 (en) 1992-12-10
IL101425A0 (en) 1992-11-15
JPH06506669A (ja) 1994-07-28
CN1065867A (zh) 1992-11-04
JP3477198B2 (ja) 2003-12-10
US5574132A (en) 1996-11-12
CA2107672C (en) 2002-11-26
JP2002128798A (ja) 2002-05-09
EP0507615A1 (en) 1992-10-07
IE921070A1 (en) 1992-10-07
NZ242183A (en) 1994-03-25
CN1051091C (zh) 2000-04-05

Similar Documents

Publication Publication Date Title
ZA922309B (en) Peptides and mixtures thereof for detecting antibodies to hepatitis c virus(hcv)
GB2239245B (en) Post-transfusional non-A non-B hepatitis viral polypeptides
HUT73098A (en) Hepatitis c virus (hcv) polypeptides
HK38293A (en) Hepatitis c virus
EP0423239A4 (en) Post-transfusion, non-a, non-b hepatitis virus and antigens
GB2212511B (en) Hepatitis c virus
EP1037974A4 (en) TRUNCATED PROTEIN OF HEPATITIS C VIRUS NS5B AND RELATED METHODS OF IDENTIFYING ANTIVIRAL COMPOUNDS
HU912118D0 (en) Non-a, non-b hepatitis virus particles
GB2108527B (en) Non-a non-b hepatitis virus
ZA912040B (en) Peptides immunochemically reactive with antibodies directed against hepatitis non-a,non-b virus
EP0532167A3 (en) Non-a, non-b hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems
EP0747482A3 (en) Recombinant hepatitis GB virus proteins their uses
ZA915286B (en) Synthetic peptides and mixtures thereof for detecting hiv antibodies
FR2690921B1 (fr) Polypeptides de synthese appartenant au virus de l'hepatite c (vhc) et utilisables notamment pour detecter ce dernier.
EP0586065A3 (en) Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same
EP1113777A4 (en) NOVEL HEPATITIS C VIRUS PEPTIDES AND USES THEREOF
EP0503950A3 (en) Method of purifying recombinant hepatitis b virus surface proteins from recombinant cells
HU9303066D0 (en) Particle forming multiply hepatitis b virus surface proteins
FI943929A (fi) Hepatiitti C-viruspeptidejä
IL118364A0 (en) A hepatitis C virus-derived composition methods for the preparation thereof and assays for the detection of hepatitis C virus
FI952778A0 (fi) Hepatiitti-C-viruksen (HCV) 3-ei-rakenne-peptidejä, vasta-aineita niitä vastaan ja menetelmiä HCV:n toteamiseksi
ZA935642B (en) Peptides analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus
AU3966995A (en) Peptides for detection of hepatitis c antibodies
AU1439195A (en) Monoclonal antibodies to hepatitis e virus and methods for using same
EP0441644A3 (en) Non-a, non-b hepatitis related nucleic acids, antigens, antibodies and their detection reagents